FDA Inspection 1306772 — Chanelle Pharmaceuticals Manufacturing Limited

Chanelle Pharmaceuticals Manufacturing Limited — FEI 3015123082

The FDA completed an inspection of Chanelle Pharmaceuticals Manufacturing Limited on Feb 3, 2023 in Loughrea. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 3, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Loughrea (Ireland)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.